ArticleTherapeutics and clinical risk management2015

Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash.

Lilia Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.